Explore how corporate venture capital and strategic partnerships are unlocking the potential of deep tech by bridging the Series B/C funding gap.
The Influencer Series is an intimate, invite-only gathering of influential, good-energy leaders. The intent is to have fun, high-impact, “dinner table” conversations with people you don't know but should. The Influencer Series has connected over 4,000 participants and 15,000 influencers in our community over the last decade.
These roundtable conversations provide a space for prominent VC funds, corporate leaders, start-up founders, academics, and other influencers to explore new ideas through an authentic and connective experience.
Alchemist Accelerator's Influencer Series: Bridging the Deep Tech Funding Gap with Corporates Accelerating Innovation
It's no secret that Silicon Valley's innovation ecosystem harbors a troubling paradox. Deep tech startups, despite showing impressive early promise and technical validation, often find themselves stranded in a financial no-man's land between initial funding rounds and commercial scale.
This funding gap hits hardest during Series B and C rounds, precisely when traditional venture capital tends to back away. These are often the companies working on solutions that could fundamentally transform our world, from breakthrough medical treatments to climate change solutions.
In this article, we'll explore how corporate venture capital, collaborative funding models, and strategic partnerships can bridge this critical gap and accelerate deep tech innovation to market.
Key takeaways
- Corporate venture capital enables longer investment horizons and strategic value creation, providing deep tech startups an important pathway beyond traditional funding constraints.
- Collaborative funding models between corporate competitors distribute risk while ensuring adequate capital for specialized technologies, creating larger market opportunities.
- Technical expertise and infrastructure from corporate partners provide effective de-risking mechanisms that pure financial capital can't match, dramatically improving success probabilities.
- Companies facing industry disruption must develop explicit long-term innovation strategies that blend internal capabilities and external innovation, particularly in sectors requiring transformation.
Understanding the Deep Tech Funding Dilemma
At the heart of this funding challenge lies a fundamental mismatch between venture capital's traditional timeframes and the realities of deep tech development. Most VC funds operate on rigid 10-year horizons, but significant advances in materials science, biotechnology, or quantum computing often need significantly longer runways to reach meaningful commercial milestones.
Because deep tech operates in specialized domains, market opportunities frequently appear deceptively small to traditional investors. What looks like a niche application today could become the foundation of an entirely new industry tomorrow. However, without the technical expertise to properly evaluate these opportunities, many financial VCs shy away from commitments that require deep domain knowledge.
Take the industrial biotech sector as a cautionary tale. Initial waves of investor enthusiasm crashed against the shores of reality when development timelines stretched far beyond initial projections. Now, despite the sector's immense potential, many promising biotech ventures struggle to secure the patient capital needed to bridge the gap between technical proof-of-concept and commercial scale.
In reality, many of these overlooked opportunities aren't necessarily more risky – they're just harder to evaluate without specialized knowledge. The same technical complexity that makes these innovations valuable creates information asymmetries that discourage investment from generalist VCs.
Corporate Venture Capital's Unique Advantage
Where traditional VCs see overwhelming complexity, corporate venture capital groups often recognize familiar technical challenges they've encountered before. This deep industrial knowledge allows corporate investors to spot valuable innovations that might appear too specialized or risky to financial investors focused purely on return multiples.
Over the last quarter century, we've seen a fundamental shift in how corporate venture arms approach investment returns. Instead of chasing unicorns, many corporate investors now recognize that strategic value can come from technologies that serve specific industry needs, even if they never achieve massive standalone valuations.
In the materials science sector, for instance, a breakthrough in cross-linking technology might never attract traditional VC attention. But for a chemical company looking to transform its product portfolio, such an innovation could represent immense strategic value. This alignment between corporate strategic interests, startup innovation timelines, and longer development cycles creates natural partnerships that can weather longer development cycles.
Consortium Models for Collaborative Innovation
A powerful shift is occurring in how corporate competitors approach innovation funding. Rather than engaging in winner-take-all battles over limited technologies, forward-thinking companies are exploring collaborative models to develop entire technology ecosystems.
Look at the semiconductor industry, where fierce competitors regularly collaborate on fundamental research while maintaining healthy competition in end products. The automotive sector shows similar evolution, with traditional rivals increasingly pooling resources to tackle challenges like electric vehicle infrastructure, autonomous driving systems, and autonomous driving systems.
Innovative funding structures are emerging to foster this collaboration. Some take the form of milestone-based prize awards that incentivize breakthrough innovations without requiring equity stakes. Others mirror DARPA's successful model of ambitious technical challenges backed by substantial development funding.
What's particularly exciting about these consortium approaches is their ability to distribute risk across multiple corporate partners. When Alchemist Accelerator facilitates these collaborations, we've seen how a lead strategic investor can catalyze broader participation, creating a template for successful deep tech funding that others can follow.
De-Risking Through Corporate Resources
Beyond pure capital, corporate venture arms bring an arsenal of resources that can dramatically accelerate deep tech development. A guaranteed customer contract from a major industry player can instantly transform a startup's risk profile, helping bridge that treacherous valley between technical validation and commercial scale.
To understand the power of corporate validation, imagine a materials science startup developing a novel polymer. Access to sophisticated testing facilities and decades of manufacturing expertise can compress development cycles from years to months. Beyond saving time, this acceleration fundamentally changes the investment calculus for other potential backers.
Here's what makes corporate partnerships particularly valuable: they provide startups with battle-tested teams who've already navigated similar technical challenges. This knowledge transfer helps young companies avoid common scaling pitfalls that often doom promising technologies.
Corporate partners also excel at translation. They can help startups reframe complex technical innovations into clear value propositions that resonate with broader investor audiences. For deep tech companies, this translation function matters significantly because revolutionary advances often hide behind impenetrable technical jargon.
Strategic Steps for Effective Corporate Innovation
In the advanced materials sector, the coming wave of decarbonization will force companies to replace 30-40% of their product portfolios with entirely new solutions. This level of transformation demands explicit planning horizons of 10-15 years, with clear acknowledgment of where external innovation becomes necessary.
But plans mean nothing without relationships to execute them. Successful corporate venture teams build strong internal bridges between their investment activities, business units, and other stakeholders. These relationships create natural pathways for external innovations to find homes within larger corporate structures.
For corporations facing disruptive changes in their core markets, the time for action is now. Structured innovation programs, like those facilitated through Alchemist Accelerator, provide proven frameworks for identifying and integrating the external innovations that will drive future growth.
Accelerating Change Through External Innovation
The pace of technological change shows no signs of slowing. In fact, across industries, the rate of disruption continues to accelerate, forcing even the most established companies to look beyond their R laboratories for competitive advantages.
What's becoming increasingly clear is that tomorrow's market leaders won't be those with the largest internal research budgets. Instead, success will flow to organizations that master the art of blending internal capabilities, strategic external innovation, and hybrid approaches. These hybrid approaches create new pathways for transformative technologies to reach markets, accelerating the pace of meaningful change across industries.
Follow the Alchemist Accelerator Influencer Series on:
Thank You to Our Notable Partners
BASF Venture Capital
Investing globally since 2001, BASF Venture Capital backs startups in Decarbonization, Circular Economy, AgTech, New Materials, Digitization, and more. Backed by BASF’s R&D and customer network, BVC plays an active role in scaling disruptive solutions.
WilmerHale
A premier international law firm with deep expertise in Corporate Venture Capital, WilmerHale operates at the nexus of government and business. Contact whlaunch@wilmerhale.com to explore how they can support your CVC strategy.
FinStrat Management is a premier outsourced financial operations firm specializing in accounting, finance, and reporting solutions for early-stage and investor-backed companies, family offices, high-net-worth individuals, and venture funds.
The firm’s core offerings include fractional CFO-led accounting + finance services, fund accounting and administration, and portfolio company monitoring + reporting. Through hands-on financial leadership, FinStrat helps clients with strategic forecasting, board reporting, investor communications, capital markets planning, and performance dashboards. The company's fund services provide end-to-end back-office support for venture capital firms, including accounting, investor reporting, and equity management.
In addition to financial operations, FinStrat deploys capital on behalf of investors through a model it calls venture assistance, targeting high-growth companies where FinStrat also serves as an end-to-end outsourced business process strategic partner. Clients benefit from improved financial insight, streamlined operations, and enhanced stakeholder confidence — all at a fraction of the cost of building an in-house team.
FinStrat also produces The Innovators & Investors Podcast, a platform that showcases conversations with leading founders, VCs, and ecosystem builders. The podcast is designed to surface real-world insights from early-stage operators and investors, with the goal of demystifying what drives successful startups and funds. By amplifying these voices, FSM supports the broader early-stage ecosystem, encouraging knowledge-sharing, connectivity, and more efficient founder-investor alignment.
Alchemist connects a global network of enterprise founders, investors, corporations, and mentors to the Silicon Valley community.
Alchemist Accelerator is a global venture-backed accelerator focused on accelerating seed-stage ventures that monetize from enterprises (not consumers). The accelerator invests in enterprise companies with distinctive technical founders and provides founders a structured path to traction, fundraising, mentorship, and community during the 6-month program.
AlchemistX partners with forward-thinking corporations and governments to deliver innovation programs worldwide. These specialized programs leverage the expertise and tools that have fueled Alchemist startups’ success since 2012. Our mission is to transform innovation challenges into opportunities.
Join our community of founders, mentors, and investors.